News related to Semprex-D (Acrivastine / Pseudoephedrine) and/or conditions it is approved for
Morria Biopharmaceuticals Plc Announces Positive Clinical Results For MRX-4 In Its Phase II Clinical Study In Allergic Rhinitis Patients
Source: Arthritis / Rheumatology News From Medical News Today [2008.11.07]
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, today announced positive data from its ICH compliant Phase II equivalent multi-center study of MRX-4 (n=105) in patients suffering from allergic rhinitis. MRX-4 was given as an intranasal spray formulation. The Nasal Allergen Challenge (NAC) study was conducted in allergic rhinitis patients outside of the local allergy season.
Children With Hay Fever More Likely To Experience Headaches, Facial Pain
Source: Headache / Migraine News From Medical News Today [2008.09.23]
Children who suffer from bouts of allergic rhinitis (hay fever) are also more likely to suffer from headaches, facial pain, and ear aches than children without these allergies, says new research presented at the 2008 American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in Chicago, IL. Allergic rhinitis is a collection of symptoms predominantly in the nose and eyes, caused by airborne particles of dust, dander, or plant pollens.
|
